Fucoidan also inhibits the migration and proliferation of HT-29 human colon cancer cells via the phosphoinositide-3 kinase/Akt/mechanistic target of rapamycin pathways [36]. This evidence concerns the gene AKT1 and malignant colon neoplasm.